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Abstract
Background: The purpose of this study is to explore the correlations of interleukin 36 (IL-36) and Soluble B7-H3
(sB7-H3) levels in bronchoalveolar lavage fluid (BALF) with clinical characteristics and laboratory findings.
Methods: A total of 35 children with M. pneumnoiae pneumonia (MPP) and 15 control subjects were enrolled. BALF
concentrations of sB7-H3 and IL-36 were detected using enzyme-linked immunosorbent assays and clinical profiles
of children with MPP were obtained.
Results: Children with MPP had significantly higher levels of sB7-H3 and IL-36 compared to control subjects (both
P < 0.05). Meanwhile, children with pleural effusion had significantly higher levels of sB7-H3 and IL-36 compared to
children without pleural effusion (both P < 0.05). BALF concentration of sB7-H3 was strongly associated with
concentration of IL-36 (r = 0.796, P < 0.0001) and sB7-H3 was correlated with duration of fever (r = 0.427, P = 0.11)
and length of stay (r = 0.345, P = 0.043). Both concentrations of sB7-H3 and IL-36 were significantly decreased in
convalescent phase after treatment (both P < 0.05).
Conclusion: Both soluble B7-H3 and IL-36 may play an important role in pathogenesis of M. pneumoniae infection
and sB7-H3 could be useful as a prognostic predictor or biomarker of MPP.
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Background
Atypical pneumonia caused by Mycoplasma pneumoniae
(M. pneumoniae) is a leading cause of mortality among
the pediatric age group. M. pneumoniae was found in
approximately 40 % of children infected with community
acquired penumonia (CAP), among which 18 % of the pa-
tients required hospitalization [1]. In the past, M. pneumo-
niae infections were considered to occur mainly in older
children, adolescents, and young adults. However, our re-
cent studies have shown that M. pneumoniae has become
an important cause of lower respiratory tract infection
(LRTI) [2] or bronchiolitis [3] in infant patients using
combined molecular and serologic methods.
M. pneumoniae infection can develop into a severe
life-threatening disease such as acute respiratory distress
syndrome, necrotizing pneumonitis, and fulminant
pneumonia [4–6], although M. pneumoniae infection is
usually a self-limited disease. Both pathogen invasion
and host immune response play roles in severe M. pneu-
moniae infection. We have reported that increased levels
of soluble B7-H3 (sB7-H3) and tumor necrosis factor-α
(TNF-α) in peripheral blood may play an important role
in immunopathogenesis of M. pneumoniae pneumonia
(MPP) [7]. In vitro, M. pneumoniae could induce inter-
leukin 1β expression and secretion in human monocytic
U937 cell lines [8]. Interleukin 36 (IL-36), another
* Correspondence: szdxjiwei@163.com; yyd3060@163.com
The author of Xin Zhao is the co-first author because of the equal
contribution.
†Equal contributors
1Department of Respiratory Disease, Children’s Hospital of Soochow
University, Soochow University, Suzhou, China
Full list of author information is available at the end of the article
© 2016 Chen et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Chen et al. BMC Infectious Diseases  (2016) 16:212 
DOI 10.1186/s12879-016-1555-6
member of the IL-1 gene family, including 3 agonistic
cytokines, namely IL-36α, IL-36β, and IL-36γ, plays a
major role in human psoriasis [9] as well as regulating
airway inflammation [10] through stimulation on den-
dritic cells and CD4+ T cells [11, 12]. IL-36α can induce
neutrophil influx and is also associated with increased
mRNA expression of neutrophil-specific chemokines
CXCL1 and CXCL2 in the lungs of C57BL/6 [13].
Meanwhile, IL-36 cytokines have a significant effect
on the development of Th1 responses [14] which have
a potential role in MPP [15], furthermore co-
stimulatory molecule B7-H3 plays a vital role in T
cells differentiation such as Th1 cells [16]. Thus, we
presume that B7-H3 might be associated with IL-36
in patients with MPP.
So far, there is no study that reported the expression
of IL-36 and sB7-H3 in bronchoalveolar lavage fluid
(BALF) of children with MPP. The purpose of this study
is to explore the associations between levels of IL-36




From Janurary 2014 to December 2014, cases with MPP
confirmed by both positive enzyme-linked immuno-
sorbent assay (ELISA) and polymerase chain reaction
(PCR) were enrolled. All cases were from 1 month to
14 years old and had fever, cough, tachypnea, chest retrac-
tions, abnormal auscultatory findings and radiologic evi-
dence of CAP. Cases were not included if they had chronic
lung disease, immunodeficiency, bronchopulmonary mal-
formation, or co-infection. Fiberoptic bronchoscopy was
applied if routine treatment of MPP (macrolide > 7 days
and methylprednisolone > 2 days) was ineffective and
patients still have a prolonged fever and radiological de-
terioration. Finally, BALF samples from 35 children di-
agnosed with MPP were collected. Radiograph of all
patients were conducted 5–7 days after the first bron-
choalveolar lavage and second bronchoalveolar lavage
was performed if there were no definitive changes be-
tween radiographs. Meanwhile, 15 BALF samples of
children with foreign body in bronchus were collected
as control group. This study was approved by the Insti-
tutional Human Ethical Committee of Children’s Hos-
pital of Soochow University and the methods were
carried out in accordance with the approved guidelines.
A written consent was obtained from all the guardians
who participated in this study.
Patient evaluation
The pediatricians completed a questionnaire regarding
the demographic and clinical data on hospital admission
and discharge. Chest radiographies of all cases were
reviewed by the radiologists. BALF samples were col-
lected from all of the enrolled children to detect com-
mon etiology using direct immunofluorescence assay
(DFA) and PCRs. All the laboratory data was reviewed
including blood rutine test, C-reactive protein concen-
tration, immunoglobulin, subpopulation of T and B lym-
phocytes. sB7-H3 and IL-36 concentrations in BALF
were detected using ELISA. Of all the cases,
convalescent BALFs in 25 children were collected.
Serology of M. pneumoniae
According to the manufacturer’s instructions, the spe-
cific antibodies against M. pneumoniae (IgG and IgM)
were detected in serum samples of children including
Table 1 Demographic and clinical data of children with MPP
Parameters Childen with MPP
Age (mean ± SD, year) 5.5 ± 2.4
Male (n, %) 19 (54.3)
Duration of fever, (25th–75th percentile, d) 15 (13–18)
Length of stay, (25th–75th percentile, d) 10 (7–13)
White blood cell counts (mean ± SD, ×109/L) 9.6 ± 4.596
Neutrophils proportion (mean ± SD, %) 70.1 ± 13.8
C-reactive protein (25th–75th percentile, mg/L) 25.4 (10.0–62.2)
ALT increase (n, %) 8 (22.9)
LDH (mean ± SD, U/L) 499.0 ± 171.8
CKMB (25th–75th percentile, U/L) 17.5 (15–24.4)
IgG (mean ± SD, g/L) 9.8 ± 4.2
IgA (25th–75th percentile, g/L) 1.4 ± 0.9
IgM (mean ± SD, g/L) 2.3 ± 1.2
CD3 + T cells (mean ± SD, %) 67.1 ± 10.9
CD3 + CD4+ T cells (mean ± SD, %) 36.6 ± 9.7
CD3-CD8+ T cells (mean ± SD, %) 26.2 ± 6.1
CD3-CD19+ B cells (mean ± SD, %) 19.2 ± 8.1
CD3-CD (16 + 56+) NK cells (mean ± SD, %) 12.0 ± 8.1





Radiologic evaluation (n, %)
Lobar or segmental opacity 33 (94.3)
Opacity with pleural effusion 12 (34.3)
Opacity with pulmonary atelectasis 3 (8.6)
Macrolide medication (n, %) 35 (100)
Methylprednisolone (n, %) 35 (100)
MPP Mycoplasma pneumoniae pneumonia, ALT alanine transarninase,
LDH L-lactate dehydrogenase, CKMB MB isoenzyme of creatine kinase,
Ig immunoglobulin, CD cluster of differentiation
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acute phase (upon admission) and convalescent phase
(upon discharge) using a commercial ELISA kit (Serion
ELISA classic M. pneumoniae IgG/IgM, Institute Virion/
Serion, Würzburg, Germany). Acute M. pneumoniae
infection was defined as either a single positive serum
IgM titer (cut-off 13 U/mL) or a 4-fold increase in the
IgG titer of convalescent serum.
BALF collection and realtime PCR for M. pneumoniae
detection
The procedure of BALF collection using fiber optic
bronchoscopy was described previously [17]. First BALF
samples were used for M. pneumoniae DNA, IL-36
and sB7-H3 detection and other BALF samples were
used for cell count after centrifugation at 200 × g for
10 min at 4 °C. M. pneumoniae DNA was detected
using a real-time PCR commercial kit (Daan Gene
Co. Ltd, Guangzhou, China) as described previously
[17]. In short, one sample of BALF was shaken for
30 s and centrifuged at 15,000 g for 5 min and the
sediment was collected for DNA extraction from a
400-μl sample in accordance with the manufacturer’s
instructions. PCR amplication was conducted using
commercial primers and probes. Quantification curves
were plotted using several concentrations of standard
control samples.
Multi-pathogen detection
Other nine viruses were detected using direct immuno-
fluorescence assay or PCRs. Seven common viruses in-
cluding respiratory syncytial virus, influenza virus types
A and B, parainfluenza virus types 1–3, and adenovirus
were detected using direct immunofluorescence assay
while human metapneumovirus and human bocavirus
were detected using PCRs as described previously [18].
Examination of sB7-H3 and IL-36 in BALF
Collected BALF samples were preserved at −80 °C for
subsequent assays after routine centrifugation. sB7-H3
ELISA kits were produced by our laboratory as previ-
ously described [19] and IL-36 ELISA kits were
purchased from R&D company. All procedures were
conducted according to the manufacturer’s instructions.
Data analysis
The Chi-square test or Fisher’s exact test were applied if
the data was numeral and the Student t-test or Mann–
Whitney U-test were applied if the data distribution was
non-normal. The Pearson or Spearman correlation test
was used to assess correlations. A two-sided p-value
of < 0.05 was considered statistically significant. All
analyses were performed using SPSS for Windows,
version 17.0 software (SPSS Inc., Chicago, IL, USA).
Fig. 1 Comparison of BALF concentration of sB7-H3 (a) and IL-36 (b) between children with MPP and control subjects as well as comparison of
sB7-H3 (c) and IL-36 (d) between children with and without pleural effusion
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Results
Demographic and clinical data of children with MPP
The demographic data, clinical characteristics and labora-
tory findings of children with MPP are shown in Table 1.
The average age of control subjects was 4.4 ± 2.4 (year),
and the male percentage was 60 % (9/15). No statistical
significance in age and gender was found between chil-
dren with MPP and control subjects.
BALF concentrations of sB7-H3 and IL-36 in children with
MPP and control subjects
As shown in Fig. 1, children with MPP had significantly
higher levels of sB7-H3 (221.3 ± 164.5 vs. 67.6 ± 45.0, pg/
ml; P = 0.0009) and IL-36 (26.5 ± 5.2 vs. 19.4 ± 5.0, pg/
ml; P < 0.0001) compared to control subjects. Among
all M. pneumoniae infected cases, children with pleural
effusion had significantly higher levels of sB7-H3
(342.6 ± 186.7 vs. 158.0 ± 110.3, pg/ml; P = 0.0008) and
IL-36 (30.6 ± 4.5 vs. 24.3 ± 4.1, pg/ml; P = 0.002) com-
pared to children without pleural effusion.
Correlation between sB7-H3, IL-36 and clinical profiles in
children with MPP
To our interest, BALF concentration of sB7-H3 was
strongly associated with concentration of IL-36 as shown
in Fig. 2. As shown in Table 2, BALF concentration of
sB7-H3 was correlated with duration of fever (r = 0.427,
P = 0.011) and length of stay (r = 0.345, P = 0.043), how-
ever no significant correlation was found between IL-36
and clinical parameters.
BALF concentrations of sB7-H3 and IL-36 before and after
treatment
All children were treated with Azithromycin (10 mg/kg.d)
and Methylprednisolone (1-2 mg/kg.d) and no severe
complications (bronchiolitis obliterans, bronchiectasis)
were found in any case within 6 months follow-up.
Convalescent BALF samples were obtained from 25 chil-
dren with MPP. Both concentrations of sB7-H3 and IL-36
significantly decreased in convalescent phase as shown in
Fig. 3.
Discussion
This study describes the expression of sB7-H3 and IL-36
in BALF samples of children with MPP and explores
the correlations with clinical profiles. Our study
shows that both BALF concentrations of sB7-H3 and
IL-36 in children with MPP were significantly in-
creased compared to control subjects and strong cor-
relation was found between sB7-H3 and IL-36. In
addition, children with pleural effusion had signifi-
cantly higher concentrations of sB7-H3 and IL-36.
Furthermore, BALF concentration of sB7-H3 was as-
sociated to duration of fever and hospital stay. We
presume that sB7-H3 may be an important prognostic
indicator to evaluate the disease severity.
Table 2 Correlation between sB7-H3, IL-36 and clinical profiles
in children with MPP
Parameters IL-36 sB7-H3
r P r P
Duration of fever (d) 0.144 0.409 0.427 0.011
Length of stay (d) 0.162 0.352 0.345 0.043
Wite blood cell counts (×109/L) −0.020 0.910 −0.143 0.411
Neutrophils percentage (%) 0.000 0.999 0.081 0.643
C-reactive protein (mg/L) 0.100 0.566 0.113 0.518
ALT increase (%) −0.169 0.332 −0.185 0.187
LDH (U/L) 0.039 0.825 0.233 0.178
CKMB (U/L) 0.006 0.971 −0.095 0.587
IgG (g/L) 0.203 0.241 0.027 0.879
IgA (g/L) −0.008 0.963 −0.117 0.505
IgM (g/L) 0.080 0.649 0.068 0.696
CD3 + T cells (%) −0.092 0.597 −0.184 0.289
CD3 + CD4+ T cells (%) −0.050 0.774 0.004 0.982
CD3-CD8+ T cells (%) −0.023 0.897 −0.141 0.421
CD3-CD19+ B cells (%) −0.042 0.809 −0.041 0.815
CD3-CD(16 + 56+)NK cells (%) 0.167 0.337 0.227 0.190
CD19 + CD23+ B cells (%) −0.163 0.349 −0.173 0.321
Cytology of BALF
Neutrophils (%) −0.221 0.201 −0.333 0.050
Lymphocytes (%) 0.089 0.610 0.048 0.786
Phagocytes (%) 0.169 0.331 0.294 0.087
MPP Mycoplasma pneumoniae pneumonia, ALT alanine transarninase,
LDH L-lactate dehydrogenase, CKMB MB isoenzyme of creatine kinase;
Ig: immunoglobulin, CD cluster of differentiation. P < 0.05 was considered
statistically significant
Fig. 2 Correlation between BALF concentration of sB7-H3 and IL-36
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Generally speaking, host immune response caused by
M. pneumoniae is a double-edged sword. On one hand,
host immune response developed by M. pneumoniae in-
fection plays a role in protection from disease deterior-
ation. On the other hand, it could lead to excessive
inflammatory response in some cases and consequently
developed into severe M. pneumoniae infection espe-
cially in older children. A wide range of cytokines and
chemokines were generated in the respiratory tracts in-
fected by M. pneumoniae, including TNF-α, IFN-γ, IL-6,
IL-8, IL-17, IL-18 [20–22] and then caused inflammatory
infiltration by neutrophils and lymphocytes [23]. In
present study, pleural effusion was a sign of excessive
inflammation indirectly induced by M. pneumoniae in-
fection because no evidence of M. pneumoniae in pleural
effusions from 3 childen was found using PCR method
(data not shown).
B7-H3, a co-stimulatory molecule, plays an important
role in the regulation of both innate and Ag-specific
T cell-mediated immune responses and inflammation
[16, 24, 25]. In our previous study, B7-H3 could be
induced by lipoproteins and functioned as a co-stimulator
of innate immunity by augmenting pro-inflammatory
cytokine (TNF-α, IL-6) release from bacterial cell wall
product-stimulated monocytes/macrophages [25]. In a
murine model of pneumococcal meningitis, B7-H3 could
augment pro-inflammatory cytokine and chemokine pro-
duction, upregulate NF-κB p65 and MAPK p38 phosphor-
ylation, and enhance the nuclear transactivation of NF-κB
p65 through TLR2-dependent mechanism [26]. Lipopro-
teins derived from M. pneumoniae could induce infiltra-
tion of leukocyte cells and production of chemokines and
cytokines in BALF [27]. In a word, B7-H3 takes part in
inflammatory pathogenesis of MPP and is a good prog-
nostic indicator.
IL-36, a cytokine of IL-1 family member, could express
both in epithelia and in immune cells [28]. A recent
study [14] demonstrated that IL-36 stimulates the ac-
tivation of naive CD4+ T cell proliferation and IL-2
production. Meanwhile, IL-36 signaling was also critical
for Th1-protective immune responses in an experimen-
tal model of Bacillus Calmette-Guerin infection [14].
Consequently, IL-36 may act as a signal to activate cells
of the innate and adaptive immunity such as DCs and
naive CD4+ T cells to stimulate host responses against
pathogens. This is the first time the high expression of
IL-36 in children with MPP and the strong correlation
with sB7-H3 were reported. All things considered, we
presume that both B7-H3 and IL-36 are crucial in
immunopathogenesis of M. pneumoniae infection and
further studies should be done to elucidate the specific
mechanism.
Conclusions
To summarize, these data support that sB7-H3 and
IL-36 may play important roles in inflammatory
pathogenesis of M. pneumoniae infection. sB7-H3
could be a useful prognostic predictor or biomarker
of MPP.
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Fig. 3 BALF concentrations of sB7-H3 and IL-36 in children with MPP before and after treatment
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